TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
Provided By PR Newswire
Last update: Feb 22, 2023
ANDOVER, Mass., Feb. 22, 2023 /PRNewswire/ - TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter and year ended December 31, 2022.
Read more at prnewswire.com118.73
+7.23 (+6.48%)
Find more stocks in the Stock Screener
TMDX Latest News and Analysis
4 days ago - ChartmillCurious about the stocks that are showing activity after the closing bell on Thursday?Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
